
This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/Alpha-GPC: Difference between revisions
Jump to navigation
Jump to search
>Kenan m Text replacement - "{{SubstanceBox <!-- Table Properties -->" to "{{SubstanceBox <!-- Special Parameters --> |displayClasses={{{displayClasses|}}}" |
>Isaak Grammatics: capitalize names |
||
(5 intermediate revisions by 4 users not shown) | |||
Line 34: | Line 34: | ||
<!-- Structure --> | <!-- Structure --> | ||
|MolecularStructureCaption=Molecular structure of alpha-GPC | |MolecularStructureCaption=Molecular structure of alpha-GPC | ||
|SkeletalImageFile=File:Alpha- | |SkeletalImageFile=File:Alpha-GPC.svg | ||
|SkeletalImageWidth=245px | |SkeletalImageWidth=245px | ||
|3DImageFile= | |3DImageFile= | ||
Line 40: | Line 40: | ||
<!-- Nomenclature --> | <!-- Nomenclature --> | ||
|NameCommon= | |NameCommon=[[common name::Alpha-GPC]], [[common name::Choline Alfoscerate]], [[common name::L-Alpha Glycerylphosphorylcholine]] | ||
|NameSubstitution= | |NameSubstitution= | ||
|NameSystematic=[(2R)-2,3-Dihydroxypropyl] 2-trimethylazaniumylethyl phosphate | |NameSystematic=[(2R)-2,3-Dihydroxypropyl] 2-trimethylazaniumylethyl phosphate | ||
<!-- Class Membership --> | <!-- Class Membership --> | ||
|EffectClass=[[Nootropic]] | |EffectClass=[[psychoactive class::Nootropic]] | ||
|ChemicalClass=[[Chemical class::Choline derivative]] | |ChemicalClass=[[Chemical class::Choline derivative]] | ||
Line 54: | Line 54: | ||
|OralROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>[[responsible drug use|See responsible use section]].</u><br> '''[[Disclaimer|DISCLAIMER]]:''' PW's [[dosage]] information is gathered from users and [[Network|resources]] for educational purposes only. It is not a recommendation. | |OralROA_Caption='''WARNING:''' Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. <u>[[responsible drug use|See responsible use section]].</u><br> '''[[Disclaimer|DISCLAIMER]]:''' PW's [[dosage]] information is gathered from users and [[Network|resources]] for educational purposes only. It is not a recommendation. | ||
|OralROA_Bioavailability= | |OralROA_Bioavailability= | ||
|OralROA_Threshold=[[Oral threshold dose::50]] | |OralROA_Threshold=[[Oral threshold dose::50]] [[Oral dose units::mg]] | ||
|OralROA_Light=[[Oral min light dose::100]] - [[Oral max light dose::300]] mg | |OralROA_Light=[[Oral min light dose::100]] - [[Oral max light dose::300]] mg | ||
|OralROA_Common=[[Oral min common dose::300]] - [[Oral max common dose::500]] mg | |OralROA_Common=[[Oral min common dose::300]] - [[Oral max common dose::500]] mg |
Latest revision as of 08:14, 13 May 2022
SubstanceBox/Alpha-GPC | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemical Nomenclature | |||||||||||||||||||||||||
Common names | Alpha-GPC, Choline Alfoscerate, L-Alpha Glycerylphosphorylcholine | ||||||||||||||||||||||||
Systematic name | [(2R)-2,3-Dihydroxypropyl] 2-trimethylazaniumylethyl phosphate | ||||||||||||||||||||||||
Class Membership | |||||||||||||||||||||||||
Psychoactive class | Nootropic | ||||||||||||||||||||||||
Chemical class | Choline derivative | ||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||
|